portdestination.blogg.se

Horizon therapeutics plc earnings
Horizon therapeutics plc earnings









horizon therapeutics plc earnings

Writing, purchasing, selling, varying etc. (i) Writing, selling, purchasing or varying

horizon therapeutics plc earnings

(c) Stock-settled derivative transactions (including options) opening/ closing a long/ short position, increasing/ reducing a long/ short position The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

  • Stock-settled derivatives (including options) and agreements to purchase/ sellĪll interests and all short positions should be disclosed.ĭetails of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.ģ.
  • Relevant securities owned and/or controlled.
  • Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security. If it is a cash offer or possible cash offer, state “N/A”
  • In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?.
  • If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)įor an opening position disclosure, state the latest practicable date prior to the disclosure.
  • Use a separate form for each offeror/offeree
  • Name of offeror/offeree in relation to whose relevant securities this form relates.
  • For a trust, the trustee(s), settlor and beneficiaries must be named. The naming of nominee or vehicle companies is insufficient.

    horizon therapeutics plc earnings

    Owner or controller of interests and short positions disclosed, if different from 1(a).RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER











    Horizon therapeutics plc earnings